Frontiers in Medicine (May 2023)

Study protocol: BRInging the Diabetes prevention program to GEriatric Populations

  • Jeannette M. Beasley,
  • Jeannette M. Beasley,
  • Emily A. Johnston,
  • Mary Ann Sevick,
  • Mary Ann Sevick,
  • Melanie Jay,
  • Melanie Jay,
  • Melanie Jay,
  • Erin S. Rogers,
  • Hua Zhong,
  • Sondra Zabar,
  • Eric Goldberg,
  • Joshua Chodosh,
  • Joshua Chodosh,
  • Joshua Chodosh

DOI
https://doi.org/10.3389/fmed.2023.1144156
Journal volume & issue
Vol. 10

Abstract

Read online

In the Diabetes Prevention Program (DPP) randomized, controlled clinical trial, participants who were ≥ 60 years of age in the intensive lifestyle (diet and physical activity) intervention had a 71% reduction in incident diabetes over the 3-year trial. However, few of the 26.4 million American adults age ≥65 years with prediabetes are participating in the National DPP. The BRInging the Diabetes prevention program to GEriatric Populations (BRIDGE) randomized trial compares an in-person DPP program Tailored for Older AdulTs (DPP-TOAT) to a DPP-TOAT delivered via group virtual sessions (V-DPP-TOAT) in a randomized, controlled trial design (N = 230). Eligible patients are recruited through electronic health records (EHRs) and randomized to the DPP-TOAT or V-DPP-TOAT arm. The primary effectiveness outcome is 6-month weight loss and the primary implementation outcome is intervention session attendance with a non-inferiority design. Findings will inform best practices in the delivery of an evidence-based intervention.

Keywords